Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1991 Jul 15;277(Pt 2):351–357. doi: 10.1042/bj2770351

A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.

T F Huang 1, J R Sheu 1, C M Teng 1
PMCID: PMC1151241  PMID: 1859363

Abstract

The interaction of fibrinogen with its receptors on platelet surfaces leads to platelet aggregation. A snake-venom peptide, trigramin, has previously been demonstrated to inhibit platelet aggregation by acting as a fibrinogen-receptor antagonist. By means of gel filtration, ionic-exchange chromatography and reverse-phase h.p.l.c., a potent platelet-aggregation inhibitor, triflavin, has now been purified from the venom of Trimeresurus flavoviridis. The purified triflavin is a single-chain polypeptide, consisting of about 71 amino acid residues with a molecular mass of 7600 Da, and its N-terminal sequence is Gly-Glu-Glu-Cys-Asp. Triflavin dose-dependently inhibited human platelet aggregation stimulated by ADP, adrenaline, collagen, thrombin or prostaglandin endoperoxide analogue U46619 in preparations of platelet-rich plasma, platelet suspension and whole blood. Its IC50 ranged from 38 to 84 nM, depending on the aggregation inducer used and the platelet preparation. However, triflavin apparently did not affect the platelet shape change and ATP-release reactions caused by these agonists. Triflavin inhibited fibrinogen-induced aggregation of human elastase-treated platelets in a dose-dependent manner, indicating that it directly interferes with the binding of fibrinogen to its receptors on platelet membranes exposed by elastase treatment. Additionally, triflavin dose-dependently blocked 125I-labelled fibrinogen binding to ADP-activated platelets. In conclusion, triflavin inhibits platelet aggregation through the blockade of fibrinogen binding to fibrinogen receptors on platelet membranes.

Full text

PDF
351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BORN G. V., CROSS M. J. THE AGGREGATION OF BLOOD PLATELETS. J Physiol. 1963 Aug;168:178–195. doi: 10.1113/jphysiol.1963.sp007185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bennett J. S., Vilaire G., Burch J. W. A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors. J Clin Invest. 1981 Oct;68(4):981–987. doi: 10.1172/JCI110352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bennett J. S., Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest. 1979 Nov;64(5):1393–1401. doi: 10.1172/JCI109597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boffa M. C., Boffa G. A. Correlations between the enzymatic activities and the factors active on blood coagulation and platelet aggregation from the venom of Vipera aspis. Biochim Biophys Acta. 1974 Jul 4;354(2):275–290. doi: 10.1016/0304-4165(74)90013-0. [DOI] [PubMed] [Google Scholar]
  5. Charo I. F., Feinman R. D., Detwiler T. C. Inhibition of platelet secretion by an antagonist of intracellular calcium. Biochem Biophys Res Commun. 1976 Oct 18;72(4):1462–1467. doi: 10.1016/s0006-291x(76)80178-7. [DOI] [PubMed] [Google Scholar]
  6. Detwiler T. C., Charo I. F., Feinman R. D. Evidence that calcium regulates platelet function. Thromb Haemost. 1978 Oct 31;40(2):207–211. [PubMed] [Google Scholar]
  7. Gan Z. R., Gould R. J., Jacobs J. W., Friedman P. A., Polokoff M. A. Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus. J Biol Chem. 1988 Dec 25;263(36):19827–19832. [PubMed] [Google Scholar]
  8. Greenberg J. P., Packham M. A., Guccione M. A., Harfenist E. J., Orr J. L., Kinlough-Rathbone R. L., Perry D. W., Mustard J. F. The effect of pretreatment of human or rabbit platelets with chymotrypsin on their responses to human fibrinogen and aggregating agents. Blood. 1979 Oct;54(4):753–765. [PubMed] [Google Scholar]
  9. Harfenist E. J., Packham M. A., Mustard J. F. Reversibility of the association of fibrinogen with rabbit platelets exposed to ADP. Blood. 1980 Aug;56(2):189–198. [PubMed] [Google Scholar]
  10. Hawiger J., Parkinson S., Timmons S. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets. Nature. 1980 Jan 10;283(5743):195–197. doi: 10.1038/283195a0. [DOI] [PubMed] [Google Scholar]
  11. Holmsen H., Setkowsky C. A., Day H. J. Effects of antimycin and 2-deoxyglucose on adenine nucleotides in human platelets. Role of metabolic adenosine triphosphate in primary aggregation, secondary aggregation and shape change of platetets. Biochem J. 1974 Nov;144(2):385–396. doi: 10.1042/bj1440385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Huang T. F., Holt J. C., Lukasiewicz H., Niewiarowski S. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. J Biol Chem. 1987 Nov 25;262(33):16157–16163. [PubMed] [Google Scholar]
  13. Huang T. F., Sheu J. R., Teng C. M., Chen S. W., Liu C. S. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex. J Biochem. 1991 Feb;109(2):328–334. [PubMed] [Google Scholar]
  14. Kornecki E., Ehrlich Y. H., De Mars D. D., Lenox R. H. Exposure of fibrinogen receptors in human platelets by surface proteolysis with elastase. J Clin Invest. 1986 Mar;77(3):750–756. doi: 10.1172/JCI112370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kornecki E., Niewiarowski S., Morinelli T. A., Kloczewiak M. Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann's thrombasthenic platelets. J Biol Chem. 1981 Jun 10;256(11):5696–5701. [PubMed] [Google Scholar]
  16. Kornecki E., Niewiarowski S., Morinelli T. A., Kloczewiak M. Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann's thrombasthenic platelets. J Biol Chem. 1981 Jun 10;256(11):5696–5701. [PubMed] [Google Scholar]
  17. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  18. Marguerie G. A., Plow E. F., Edgington T. S. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem. 1979 Jun 25;254(12):5357–5363. [PubMed] [Google Scholar]
  19. Morinelli T. A., Niewiarowski S., Kornecki E., Figures W. R., Wachtfogel Y., Colman R. W. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues. Blood. 1983 Jan;61(1):41–49. [PubMed] [Google Scholar]
  20. Mustard J. F., Packham M. A., Kinlough-Rathbone R. L., Perry D. W., Regoeczi E. Fibrinogen and ADP-induced platelet aggregation. Blood. 1978 Aug;52(2):453–466. [PubMed] [Google Scholar]
  21. Mustard J. F., Perry D. W., Ardlie N. G., Packham M. A. Preparation of suspensions of washed platelets from humans. Br J Haematol. 1972 Feb;22(2):193–204. doi: 10.1111/j.1365-2141.1972.tb08800.x. [DOI] [PubMed] [Google Scholar]
  22. Ouyang C., Huang T. F. Inhibition of platelet aggregation by 5'-nucleotidase purified from Trimeresurus gramineus snake venom. Toxicon. 1983;21(4):491–501. doi: 10.1016/0041-0101(83)90127-7. [DOI] [PubMed] [Google Scholar]
  23. Ouyang C., Huang T. F. Platelet aggregation inhibitors from Agkistrodon acutus snake venom. Toxicon. 1986;24(11-12):1099–1106. doi: 10.1016/0041-0101(86)90136-4. [DOI] [PubMed] [Google Scholar]
  24. Ouyang C., Huang T. F. Potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom. Biochim Biophys Acta. 1983 Jun 9;757(3):332–341. doi: 10.1016/0304-4165(83)90059-4. [DOI] [PubMed] [Google Scholar]
  25. Ouyang C., Teng C. M., Huang T. F. Characterization of the purified principles of Formosan snake venoms which affect blood coagulation and platelet aggregation. Taiwan Yi Xue Hui Za Zhi. 1982 Jul;81(7):781–790. [PubMed] [Google Scholar]
  26. Phillips D. R., Charo I. F., Parise L. V., Fitzgerald L. A. The platelet membrane glycoprotein IIb-IIIa complex. Blood. 1988 Apr;71(4):831–843. [PubMed] [Google Scholar]
  27. Plow E. F., Marguerie G. A. Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP. J Biol Chem. 1980 Nov 25;255(22):10971–10977. [PubMed] [Google Scholar]
  28. Plow E. F., Marguerie G. A. Participation of ADP in the binding of fibrinogen to thrombin-stimulated platelets. Blood. 1980 Sep;56(3):553–555. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES